Monash IVF Group Gestione

Gestione criteri di controllo 3/4

Monash IVF Group Il CEO è Michael Knaap, nominato in Oct2018, e ha un mandato di 6.08 anni. la retribuzione annua totale è A$ 1.21M, composta da 49.8% di stipendio e 50.2% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.23% delle azioni della società, per un valore di € 634.82K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.3 anni e 8.1 anni.

Informazioni chiave

Michael Knaap

Amministratore delegato

AU$1.2m

Compenso totale

Percentuale dello stipendio del CEO	49.8%
Mandato del CEO	6.1yrs
Proprietà del CEO	0.2%
Durata media del management	5.3yrs
Durata media del Consiglio di amministrazione	8.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Michael Knaap rispetto agli utili di Monash IVF Group?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	AU$1m	AU$601k	-AU$7m
Mar 31 2024	n/a	n/a	AU$9m
Dec 31 2023	n/a	n/a	AU$24m
Sep 30 2023	n/a	n/a	AU$23m
Jun 30 2023	AU$1m	AU$567k	AU$22m
Mar 31 2023	n/a	n/a	AU$19m
Dec 31 2022	n/a	n/a	AU$17m
Sep 30 2022	n/a	n/a	AU$18m
Jun 30 2022	AU$794k	AU$552k	AU$18m
Mar 31 2022	n/a	n/a	AU$21m
Dec 31 2021	n/a	n/a	AU$23m
Sep 30 2021	n/a	n/a	AU$24m
Jun 30 2021	AU$908k	AU$501k	AU$25m
Mar 31 2021	n/a	n/a	AU$22m
Dec 31 2020	n/a	n/a	AU$18m
Sep 30 2020	n/a	n/a	AU$15m
Jun 30 2020	AU$561k	AU$479k	AU$12m
Mar 31 2020	n/a	n/a	AU$15m
Dec 31 2019	n/a	n/a	AU$18m
Sep 30 2019	n/a	n/a	AU$19m
Jun 30 2019	AU$520k	AU$402k	AU$20m
Mar 31 2019	n/a	n/a	AU$19m
Dec 31 2018	n/a	n/a	AU$19m
Sep 30 2018	n/a	n/a	AU$20m
Jun 30 2018	AU$424k	AU$350k	AU$21m

Compensazione vs Mercato: La retribuzione totale di Michael ($USD 789.17K ) è circa la media per le aziende di dimensioni simili nel mercato German ($USD 786.79K ).

Compensazione vs guadagni: La retribuzione di Michael è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Michael Knaap

6.1yrs

Mandato

AU$1,207,516

Compensazione

Mr. Michael D. Knaap serves as Chief Executive Officer, Managing Director and Executive Director of Monash IVF Group Limited since April 15, 2019. Mr. Knaap served as an Interim Chief Executive Officer of...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Michael Knaap	CEO, MD & Executive Director	6.1yrs	AU$1.21m	0.23% € 634.8k
Malik Jainudeen	Group CFO & Company Secretary	5.6yrs	AU$583.85k	0.0049% € 13.8k
Hamish Hamilton	Chief Operating Officer	4.7yrs	AU$608.35k	0.041% € 115.7k
Richard Henshaw	Executive Director	10.6yrs	AU$393.90k	0.35% € 974.4k
Deirdre Zander-Fox	Chief Scientific Officer	no data	Nessun dato	Nessun dato
Thierry Panthier	Chief Information Officer	2.8yrs	Nessun dato	Nessun dato
Fiona Allen	Chief Marketing Officer	5.3yrs	Nessun dato	Nessun dato
Peggy North	Chief People & Culture Officer	no data	Nessun dato	Nessun dato
Tedd Fuell	Chief Governance & Risk Officer	no data	Nessun dato	Nessun dato
Johannes Lagerwij	Managing Director of Asia	1.8yrs	Nessun dato	Nessun dato

5.3yrs

Durata media

Gestione esperta: Il team dirigenziale di MIS è esperto e expertise (durata media dell'incarico 5.3 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Michael Knaap	CEO, MD & Executive Director	5.6yrs	AU$1.21m	0.23% € 634.8k
Richard Henshaw	Executive Director	10.6yrs	AU$393.90k	0.35% € 974.4k
Neil Broekhuizen	Independent Non-Executive Director	10.4yrs	AU$107.65k	0.090% € 251.0k
Richard Davis	Independent Non-Executive Chairman	10.4yrs	AU$183.69k	0.047% € 130.6k
Zita Peach	Independent Non-Executive Director	8.1yrs	AU$117.03k	0.024% € 66.6k
Catherine West	Independent Non-Executive Director	4.2yrs	AU$107.65k	0.0095% € 26.6k
Catherine Aston	Independent Non-Executive Director	less than a year	AU$35.88k	0.020% € 55.2k

8.1yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MIS sono considerati esperti (durata media dell'incarico 8.1 anni).

Monash IVF Group Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought €57k worth of stock

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Insufficient new directors

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Recent updates

New minor risk - Share price stability

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought €57k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought €124k worth of stock

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: €0.51

New 90-day high: €0.48

New 90-day high: €0.44

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Membri del Consiglio di amministrazione

Durata media

Età media